Variant report
Variant | esv2754928 |
---|---|
Chromosome Location | chr3:24913845-24957017 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:57861594..57864060-chr3:24935061..24936561,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000267637 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150327050 | chr3:24919003-24919004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548704987 | chr3:24919040-24919041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571827395 | chr3:24919047-24919048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576351030 | chr3:24919053-24919054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs77415150 | chr3:24919062-24919063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528339579 | chr3:24919095-24919096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570480375 | chr3:24919109-24919110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548393440 | chr3:24919134-24919135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200428189 | chr3:24919171-24919172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552972650 | chr3:24919186-24919187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115655805 | chr3:24919190-24919191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12493197 | chr3:24919200-24919201 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs144362251 | chr3:24919206-24919207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs139010006 | chr3:24919218-24919219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545057747 | chr3:24919285-24919286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575412890 | chr3:24919289-24919290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185414221 | chr3:24919296-24919297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141178810 | chr3:24919309-24919310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190216882 | chr3:24919321-24919322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541737331 | chr3:24919364-24919365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559780112 | chr3:24919365-24919366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs565406959 | chr3:24919378-24919379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542061238 | chr3:24919388-24919389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563501152 | chr3:24919399-24919400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530865557 | chr3:24924229-24924230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552296034 | chr3:24924234-24924235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564469519 | chr3:24924235-24924236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs376768430 | chr3:24924278-24924279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs571047918 | chr3:24924322-24924323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs546848705 | chr3:24924343-24924344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs138157683 | chr3:24924382-24924383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535639634 | chr3:24924397-24924398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142535802 | chr3:24924414-24924415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs2362775 | chr3:24924421-24924422 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs539500536 | chr3:24924427-24924428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557486412 | chr3:24924443-24924444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190648316 | chr3:24924473-24924474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535035535 | chr3:24924478-24924479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571778962 | chr3:24924494-24924495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs6550923 | chr3:24924495-24924496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554262553 | chr3:24924510-24924511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs375668262 | chr3:24924533-24924534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542020725 | chr3:24924543-24924544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545947722 | chr3:24924549-24924550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557091154 | chr3:24924678-24924679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370354034 | chr3:24924705-24924706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs575348538 | chr3:24924753-24924754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546248491 | chr3:24924794-24924795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368557682 | chr3:24924848-24924849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs3221508 | chr3:24924850-24924851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:24919000-24919400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr3:24924200-24924600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr3:24924600-24928000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr3:24927800-24928400 | Enhancers | Fetal Kidney | kidney |
5 | chr3:24928000-24928200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr3:24928000-24928200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr3:24928200-24929400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr3:24929400-24929600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr3:24930400-24930600 | Enhancers | Fetal Lung | lung |
10 | chr3:24930600-24931600 | Weak transcription | Fetal Lung | lung |
11 | chr3:24931600-24931800 | Enhancers | Fetal Lung | lung |
12 | chr3:24934000-24934200 | Enhancers | Fetal Lung | lung |
13 | chr3:24940400-24942600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr3:24943800-24944000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr3:24948400-24949400 | Enhancers | Fetal Lung | lung |
16 | chr3:24952000-24952600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr3:24952000-24952800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |